State Board of Administration of Florida Retirement System grew its position in Zynex, Inc. (NASDAQ:ZYXI – Get Rating) by 76.0% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 20,107 shares of the company’s stock after buying an additional 8,682 shares during the period. State Board of Administration of Florida Retirement System owned 0.05% of Zynex worth $280,000 at the end of the most recent quarter.
Other institutional investors have also modified their holdings of the company. Altshuler Shaham Ltd purchased a new position in shares of Zynex during the 3rd quarter valued at approximately $27,000. PNC Financial Services Group Inc. raised its holdings in Zynex by 1,213.7% in the 1st quarter. PNC Financial Services Group Inc. now owns 4,309 shares of the company’s stock valued at $28,000 after buying an additional 3,981 shares during the period. Teachers Retirement System of The State of Kentucky purchased a new stake in Zynex during the third quarter worth about $43,000. UBS Group AG increased its stake in Zynex by 49.0% during the third quarter. UBS Group AG now owns 5,371 shares of the company’s stock worth $49,000 after purchasing an additional 1,766 shares during the period. Finally, Raymond James Financial Services Advisors Inc. purchased a new stake in shares of Zynex during the first quarter worth approximately $66,000. 28.64% of the stock is currently owned by institutional investors.
Zynex Stock Up 0.5 %
Shares of NASDAQ:ZYXI opened at $9.63 on Monday. The company has a debt-to-equity ratio of 0.06, a quick ratio of 2.42 and a current ratio of 3.09. Zynex, Inc. has a 1 year low of $6.56 and a 1 year high of $17.25. The stock has a market capitalization of $352.99 million, a P/E ratio of 21.40 and a beta of 0.58. The stock has a 50-day simple moving average of $11.19 and a 200-day simple moving average of $12.80.
Analysts Set New Price Targets
Several equities research analysts recently weighed in on the company. TheStreet downgraded Zynex from a “b-” rating to a “c” rating in a report on Friday, April 28th. LADENBURG THALM/SH SH increased their price objective on Zynex from $27.00 to $28.00 and gave the company a “buy” rating in a research note on Tuesday, March 28th. Finally, HC Wainwright reissued a “buy” rating and issued a $20.00 price target on shares of Zynex in a research note on Wednesday, April 12th.
Zynex, Inc engages in the design, manufacture, and marketing of medical devices. It sells electrotherapy medical devices used for pain management and rehabilitation. It also develops a new blood volume monitor for use in hospitals and surgery centers. The company was founded by Thomas Sandgaard in 1996 and is headquartered in Englewood, CO.
- Get a free copy of the StockNews.com research report on Zynex (ZYXI)
- MarketBeat Week in Review – 5/15 – 5/19
- Applied Materials: Cracks In The Chip Recovery Or Time To Buy?
- Deere & Company Rallies On Farm Equipment Boom, Bullish Outlook
- How Many Roth IRAs Can You Have?
- Why You Should Consider Buying Nvidia Ahead Of Earnings
Want to see what other hedge funds are holding ZYXI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zynex, Inc. (NASDAQ:ZYXI – Get Rating).
Receive News & Ratings for Zynex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zynex and related companies with MarketBeat.com's FREE daily email newsletter.